Abstract: Microfluidic devices are provided for trapping, isolating, and processing single cells. The microfluidic devices include a cell capture chamber having a cell funnel positioned within the cell capture chamber to direct a cell passing through the cell capture chamber towards one or more a cell traps positioned downstream of the funnel to receive a cell flowing. The devices may further include auxiliary chambers integrated with the cell capture chamber for subsequent processing and assaying of the contents of a captured cell. Methods for cell capture and preparation are also provided that include flowing cells through a chamber, funneling the cells towards a cell trap, capturing a predefined number of the cells within the trap, interrupting the flow of cells, flowing a wash solution through the chamber to remove contaminants from the chamber, and sealing the predefined number of cells in the chamber.
Type:
Grant
Filed:
May 27, 2011
Date of Patent:
February 27, 2018
Assignee:
The University of British Columbia
Inventors:
Carl Lars Genghis Hansen, Michael VanInsberghe, Adam White, Oleh Petriv, Tim Leaver, Anupam Singhal, William Bowden, Veronique Lecault, Dan Da Costa, Leo Wu, Georgia Russell, Darek Sikorski
Abstract: The porous polymer compound has a three dimensional skeleton and pores and/or voids that are partitioned and formed by the three dimensional skeleton. The three dimensional skeleton comprises multiple sugar derivatives represented by formula (1) and multiple cations that interact with the hydroxyl groups and/or ether bonds of the sugar derivatives, and the three-dimensional skeleton is formed by each of the cations interacting with two or more sugar derivatives. Also provided are a method of separating a compound to be separated using the porous polymer compound; a single crystal of the porous polymer compound; a method of preparing a sample for crystal structure analysis using the single crystal; a method of determining a molecular structure of a compound to be analyzed using the sample for crystal structure analysis; and a method of determining an absolute configuration of a chiral compound using the sample for crystal structure analysis.
Abstract: Disclosed are various embodiments that relates to executing a sequence of messaging nodes, where the messaging sequence is defined by user-defined local triggering conditional expressions for each messaging node, and supporting proper data organization and links that integrate individual message instances in a protocol flow.
Type:
Application
Filed:
August 18, 2017
Publication date:
February 22, 2018
Applicant:
Board of Regents, The University of Texas System
Inventors:
David Akopian, Rodrigo David Escobar Palacios, Sahak Igor Kaghyan
Abstract: The present invention provides methods and systems for 3D imaging of in vivo and ex vivo tissues. The disclosed systems and methods employ an autoradiographic approach where particles emitted by a radioactive composition within the tissue are detected. Once detected, a 3D representation of the source of particles within the tissue is reconstructed for viewing and analysis.
Type:
Application
Filed:
October 10, 2017
Publication date:
February 22, 2018
Applicants:
Arizona Board of Regents on Behalf of The University of Arizona, inviCRO, LLC
Inventors:
Harrison H. BARRETT, Brian MILLER, Yijun DING, Liying CHEN, John William HOPPIN, Luca CAUCCI
Abstract: In some embodiments, an anti-corrosive composite ceramic coating includes an inner metal layer formed on the surface of a metal object to be protected and an outer composite ceramic layer formed on the inner metal layer.
Type:
Application
Filed:
March 4, 2016
Publication date:
February 22, 2018
Applicant:
Board of Regents, The University of Texas System
Inventors:
GEORGE KENNETH RICE, MIGUEL JOSE YACAMAN, EKATERINA VINOGRADOVA
Abstract: Described herein, inter alia, are compositions, oleagnious organisms, and methods useful for producing lipids, lipid precursors, and/or oleochemicals.
Type:
Grant
Filed:
May 2, 2014
Date of Patent:
February 20, 2018
Assignee:
Board of Regents, The University of Texas System
Inventors:
John Blazeck, Andrew Hill, Leqian Liu, Hal Alper
Abstract: Methods and compositions for depositing a monolayer onto a surface of a substrate are described. The method can include contacting the surface with a vapor phase comprising a carbene source, and reacting a carbene group from the carbene source with a functional group on the surface, to obtain a covalently bound monolayer on the surface of the substrate. The carbene source can be a diazirine compound. The functional group on the surface can be a C—H containing group, a Si—H containing group, among others, or combinations thereof. The method can further involve removing physisorbed molecules from the surface of the substrate.
Type:
Grant
Filed:
April 15, 2016
Date of Patent:
February 20, 2018
Assignee:
The University of Rochester
Inventors:
Alexander Shestopalov, James McGrath, Xunzhi Li
Abstract: The present invention includes a hydrogel and a method of making a porous hydrogel by preparing an aqueous mixture of an uncrosslinked polymer and a crystallizable molecule; casting the mixture into a vessel; allowing the cast mixture to dry to form an amorphous hydrogel film; seeding the cast mixture with a seed crystal of the crystallizable molecule; growing the crystallizable molecule into a crystal structure within the uncrosslinked polymer; crosslinking the polymer around the crystal structure under conditions in which the crystal structure within the crosslinked polymer is maintained; and dissolving the crystals within the crosslinked polymer to form the porous hydrogel.
Type:
Grant
Filed:
April 22, 2016
Date of Patent:
February 20, 2018
Assignee:
Board of Regents, The University of Texas System
Abstract: An object of the present invention is to provide a preventive and/or therapeutic agent for radiation damage that has a novel mechanism of action and can prevent and alleviate a wide range of symptoms of radiation damage for which no therapeutic measures have been available so far, and moreover, is highly safe to humans. A preventive and/or therapeutic agent for radiation damage comprising a compound represented by the following formula (I) such as 5-aminolevulinic acid (5-ALA) or a salt thereof as an active ingredient can be used to improve the survival rate, improve body weight reduction, and alleviate hematopoietic disorder: (wherein R1 represents a hydrogen atom or an acyl group; and R2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group).
Type:
Grant
Filed:
July 11, 2013
Date of Patent:
February 20, 2018
Assignees:
The University of Tokyo, SBI Pharmaceuticals Co., Ltd.
Abstract: The present invention comprises apparatuses and methods of detecting impacts to the head. Accelerometers attached to a user's head and neck or body is used to measure the differential acceleration of the head with respect to the neck or body. A differential acceleration exceeding a certain threshold may be indicative of the user suffering a traumatic brain injury.
Type:
Grant
Filed:
February 27, 2015
Date of Patent:
February 20, 2018
Assignee:
Board of Regents, The University of Texas System
Abstract: Compositions and method for treating a folate-resistant disease in a subject are disclosed. The methods involve administering to the subject an effective amount of a composition containing a formate. For example, the method can be used to reducing the risk of neural tube defects during pregnancy. The method can also be used to treat other conditions normally treatable by folate supplementation.
Type:
Grant
Filed:
August 13, 2014
Date of Patent:
February 20, 2018
Assignee:
Board of Regents, The University of Texas System
Abstract: The present invention relates to methods of assessing whether a subject has or is likely to develop a neurodegenerative disease comprising determining whether the subject has a mutation in the C9orf72 gene wherein said mutation prevents or disrupts C9orf72 expression relative to expression in a reference from subjects without the mutation.
Type:
Grant
Filed:
August 31, 2012
Date of Patent:
February 20, 2018
Assignees:
The University of Manchester, National Institute of Aging, Hospital District of Helsinki and UUSIMAA, VU University Medical Centre Armsterdam, UCL Business PLC, University College Cardiff Consultants Limited
Inventors:
Stuart Pickering-Brown, Bryan Traynor, Andrew B. Singleton, Huw Morris, Peter Heutink, John Hardy, Pentti Tienari
Abstract: Methods, systems, and computer readable media for low latency stabilization for head-worn displays are disclosed. According to one aspect, the subject matter described herein includes a system for low latency stabilization of a head-worn display. The system includes a low latency pose tracker having one or more rolling-shutter cameras that capture a 2D image by exposing each row of a frame at a later point in time than the previous row and that output image data row by row, and a tracking module for receiving image data row by row and using that data to generate a local appearance manifold. The generated manifold is used to track camera movements, which are used to produce a pose estimate.
Type:
Grant
Filed:
March 13, 2014
Date of Patent:
February 20, 2018
Assignee:
The University of North Carolina at Chapel Hill
Inventors:
Henry Fuchs, Anselmo A. Lastra, Jan-Michael Frahm, Nate Michael Dierk, David Paul Perra
Abstract: An encoding apparatus is an encoding apparatus for encoding a time-series signal for each of predetermined time sections in a frequency domain, wherein a parameter ? is a positive number, the parameter ? corresponding to a time-series signal is a shape parameter of generalized Gaussian distribution that approximates a histogram of a whitened spectral sequence, which is a sequence obtained by dividing a frequency domain sample sequence corresponding to the time-series signal by a spectral envelope estimated by regarding the ?-th power of absolute values of the frequency domain sample sequence as a power spectrum, and any of a plurality of parameters ? is selective or the parameter ? is variable for each of the predetermined time sections; and the encoding apparatus comprises an encoding portion encoding the time-series signal for each of the predetermined time sections by an encoding process with a configuration identified at least based on the parameter ? for each of the predetermined time sections.
Type:
Application
Filed:
January 27, 2016
Publication date:
February 15, 2018
Applicants:
NIPPON TELEGRAPH AND TELEPHONE CORPORATION, The University of Tokyo
Abstract: The present invention provides that exosomes from human body fluid samples contain double stranded genomic DNA that spans all chromosomes and may be used to determine the mutation status of genes of interest in diseases, such as cancer. Furthermore, the present invention provides the use of exosomes to produce therapeutic proteins and for their use in therapy as well as the detection of cancer cell-derived exosomes to diagnose cancer and monitor therapeutic response.
Type:
Application
Filed:
November 1, 2017
Publication date:
February 15, 2018
Applicant:
Board of Regents, The University of Texas System
Abstract: The present invention includes pharmaceutical liposome formulation thereof comprising a N-(2-aminoethyl) ethanolamine (AEEA) and/or active analogs thereof in a liposome, wherein the N-(2-aminoethyl) ethanolamine (AEEA) and/or active analogs thereof are provided in an amount sufficient to treat or reduce scarring of the skin or eye.
Type:
Application
Filed:
August 10, 2017
Publication date:
February 15, 2018
Applicant:
Board of Regents, The University of Texas System
Abstract: The present invention relates to the field of immunology and hyperproliferative diseases. More specifically, the present invention relates to a method of detecting and monitoring therapeutic antibody:antigen complex, soluble antigen and soluble therapeutic antibody, wherein a patient has undergone at least one course of immunotherapy. Yet further, levels of therapeutic antibody:antigen complexes, soluble antigens or soluble therapeutic antibodies may be measured and used to stage or monitor a hyperproliferative disease.
Type:
Application
Filed:
May 26, 2017
Publication date:
February 15, 2018
Applicant:
Board of Regents, The University of Texas System
Inventors:
Maher ALBITAR, Michael J. KEATING, Taghi MANSHOURI
Abstract: A method for fabricating a nanopore at a particular location in a membrane includes controlling a dielectric strength of the membrane at a particular location on the membrane while applying one of an electric potential or an electric current to the membrane, monitoring an electrical property across the membrane while one of the electric potential or the electric current is being applied across the membrane, detecting an abrupt change in the electrical property across the membrane while one of the electric potential or the electric current is being applied across the membrane; and removing the electric potential or the electric current from the membrane in response to detecting the abrupt change in the electrical property.
Type:
Application
Filed:
February 24, 2016
Publication date:
February 15, 2018
Applicant:
The University of Ottawa
Inventors:
Jose BUSTAMANTE, Kyle BRIGGS, Vincent TABARD-COSSA
Abstract: Systems, devices, and methods are described herein for generating liquid water from water vapor present in the atmosphere through use of selectively permeable films that permit water to pass through but that block other liquids and gases, such as atmospheric gases. The systems, devices, and methods employ condensation techniques in which only the water that is passed through the selectively permeable film is cooled, as compared to other atmospheric water generation systems, which cool water and other gases that enter with the water.
Type:
Application
Filed:
February 8, 2016
Publication date:
February 15, 2018
Applicant:
Board of Regents, The University of Texas System